<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our aim was to investigate the effect of chemotherapy on plasma total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity and <z:chebi fb="0" ids="26195">polyphenols</z:chebi> in patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma samples were collected from 70 CRC patients under chemotherapy treatment, and 15 non-treated patients </plain></SENT>
<SENT sid="2" pm="."><plain>The control group included 71 healthy individuals </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma ABTS and FRAP were measured as biomarkers of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> total capacity and the total <z:chebi fb="43" ids="15882">phenols</z:chebi> as an indicator to determine the <z:chebi fb="0" ids="26195">polyphenols</z:chebi> levels in plasma </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment with chemotherapy protocols resulted in a significant decrease of ABTS (-24 %, p &lt; 0.048), FRAP (-15 %, p &lt; 0.046) and <z:chebi fb="0" ids="26195">polyphenols</z:chebi> (-46 %, p &lt; 0.05) compared with the values of those not treated </plain></SENT>
<SENT sid="5" pm="."><plain>The total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity was significantly lower (-18 % for ABTS and -12 % for FRAP) in patients with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> as compared with patients without <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The plasma total <z:chebi fb="43" ids="15882">phenols</z:chebi>, were also decreased (-16 %, p = 0.005) in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>The patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> have decreased total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity and the values are lower in patients treated with chemotherapy </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, CEA <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker levels are associated with a lower plasma total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity, and therefore with the progress and development of the disease </plain></SENT>
</text></document>